Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
8th grade Avg
|
New words:
agent, alleged, Appendix, appointment, breach, cardiac, Carr, case, children, clearance, cleared, client, Codification, complaint, Conference, contract, County, Court, CRI, daily, District, DMDTM, efficacy, ejection, Exasperated, excellence, failed, FIGHT, FIGHTING, Footnote, fraction, function, half, hiring, Ingram, IPF, Ketorolac, leg, Melinta, meloxicam, MRI, multicenter, muscle, NDA, newborn, newly, profile, Project, provisional, quantitative, randomized, rare, refiled, renal, Restated, ROU, Schedule, settlement, shown, sNDA, Southern, strength, Supreme, Targanta, trend, unfavorable, usage, ventricular, young
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view